Literature DB >> 15372363

Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus.

A Wedrychowicz1, H Dziatkowiak, K Sztefko, A Wedrychowicz1.   

Abstract

BACKGROUND: Some studies suggest that IL-6 is connected with glucose metabolism and insulin action, so like IGF-IGFBPs system it could play the role in diabetes etiopathogenesis. AIM: The aim of the study was therefore to test the hypothesis that in children and adolescents IL-6 is of importance for the etiopathogenesis of diabetes mellitus type 1 and that IL-6 is connected with carbohydrate metabolism and IGF-IGFBPs action.
METHODS: There were 49 patients with type 1 diabetes: 10 persons at onset diabetes and 39 with disease lasted at least 1 year and 33 age-matched healthy children included into the study. Serum IGF-I concentrations were measured by RIA; IGFBP-1 and IGFBP-2 by IRMA and IL-6 concentrations using quantitative ELISA immunoassays. HbA1c was measured by HPLC method. Multiple regression, ANOVA, and Student's t-test were used for statistical analysis.
RESULTS: IL-6 and IGF-I, IGFBP-1 and IGFBP-2 levels did not differ statistically significant between diabetic patients and controls. IL-6 concentrations were statistically higher at onset diabetes than in diabetic patients with long-term disease. IL-6 did not correlate with IGF-I and its binding proteins - 1 and - 2 in examined groups. At onset of disease IL-6 correlated with insulin requirement. There were not found correlations between IL-6 and HbA1c in diabetic groups. IGF-I positively correlated with age and growth in both groups and with IGFBP-2 in diabetic patients. IGFBP-2 correlated negatively with BMI in all examined groups.
CONCLUSIONS: IL-6 might play a significant role in type 1 diabetes mellitus etiopathogenesis. It seems that IL-6 does not regulate IGF-IGFBP system in diabetic children and adolescents or IL-6 maybe cooperate with IGF-I, but their significant dependence on insulin action influences their mutual relationships.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372363     DOI: 10.1055/s-2004-821189

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

Review 1.  Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.

Authors:  Manish Raisingani; Brar Preneet; Brenda Kohn; Shoshana Yakar
Journal:  Growth Horm IGF Res       Date:  2017-04-28       Impact factor: 2.372

2.  Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study.

Authors:  Janet K Snell-Bergeon; Nancy A West; Elizabeth J Mayer-Davis; Angela D Liese; Santica M Marcovina; Ralph B D'Agostino; Richard F Hamman; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2010-04-06       Impact factor: 5.958

3.  Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Authors:  Xianwen Yi; Longquan Xu; Sylvia Hiller; Hyung-Suk Kim; Nobuyo Maeda
Journal:  Atherosclerosis       Date:  2012-05-16       Impact factor: 5.162

4.  Beta-cell specific production of IL6 in conjunction with a mainly intracellular but not mainly surface viral protein causes diabetes.

Authors:  Tom L Van Belle; Philippe P Pagni; Jeanette Liao; Sowbarnika Sachithanantham; Amy Dave; Amira Bel Hani; Yulia Manenkova; Natalie Amirian; Cheng Yang; Bret Morin; Haiqing Zhang; Iain L Campbell; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2014-02-26       Impact factor: 7.094

5.  Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.

Authors:  Christian Hundhausen; Alena Roth; Elizabeth Whalen; Janice Chen; Anya Schneider; S Alice Long; Shan Wei; Rebecca Rawlings; MacKenzie Kinsman; Stephen P Evanko; Thomas N Wight; Carla J Greenbaum; Karen Cerosaletti; Jane H Buckner
Journal:  Sci Transl Med       Date:  2016-09-14       Impact factor: 17.956

6.  Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.

Authors:  Yasar Dogan; Saadet Akarsu; Bilal Ustundag; Erdal Yilmaz; Metin Kaya Gurgoze
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

7.  Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes.

Authors:  Hany M Ibrahim; Ibrahim A El-Elaimy; Heba M Saad Eldien; Badr Mohamed Badr; Danny M Rabah; Gamal Badr
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

8.  The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes.

Authors:  Monika Ryba-Stanisławowska; Maria Skrzypkowska; Jolanta Myśliwska; Małgorzata Myśliwiec
Journal:  Mediators Inflamm       Date:  2013-02-21       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.